U.S. Professional Services Stock News

NasdaqGS:IEP
NasdaqGS:IEPIndustrials

Icahn Enterprises (IEP) Valuation Check After Higher NAV And Quarterly Loss

Quarterly results put Icahn Enterprises in focus Icahn Enterprises (IEP) just released quarterly results that combined a higher Indicative Net Asset Value tied to its CVI holdings with a GAAP net loss and a fresh cash or unit distribution decision for unitholders. See our latest analysis for Icahn Enterprises. The latest quarterly update has been met with a relatively muted reaction, with the 1-day share price return of 0.67% and 7-day share price return of 0.54% sitting against a 30-day...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron Pharmaceuticals (REGN) Valuation Check After CytomX Collaboration Expansion And Lynozyfic Trial Update

Regeneron Pharmaceuticals (REGN) is back in focus after expanding its cancer research partnership with CytomX Therapeutics and reporting early clinical results for Lynozyfic in light chain amyloidosis, which together have supported fresh interest in the stock. See our latest analysis for Regeneron Pharmaceuticals. Despite the positive reaction to the CytomX expansion and Lynozyfic data, Regeneron’s 1-day share price return of 1.58% sits against a year-to-date share price decline of 19.01%...
NYSE:DQ
NYSE:DQSemiconductor

What Daqo New Energy (DQ)'s RMB 6 Billion AI Data Center Power Push Means For Shareholders

Daqo New Energy’s subsidiary Daqo Energy Technology (Shanghai) Co. Ltd. has signed an agreement to build a new Kunshan manufacturing base focused on R&D, production, and sales of next-generation energy solutions for AI data centers, including energy storage systems, solid-state transformers, circuit breakers, and batteries, with Phase 1 investment of about RMB 2,100 million and a preliminary total of about RMB 6.00 billion, although the future impact on performance remains uncertain. This...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Valuation Check After AI Rackscale Launch And New Data Center Partnerships

Intel (INTC) just put its AI data center story front and center, unveiling rackscale AI infrastructure, new Xeon 6+ CPUs built on its 18A process, and partnerships with Foxconn, SambaNova, Siemens, Hitachi, and others. See our latest analysis for Intel. The latest AI rackscale push and Foxconn partnership come after a sharp run, with the 90 day share price return of 157.44% and a very large 1 year total shareholder return of 459.18%. Recent 7 day weakness hints at some cooling momentum after...
NYSE:CARR
NYSE:CARRBuilding

Is Carrier Global (CARR) Now Attractive After Strong Year To Date Share Price Gains?

Wondering if Carrier Global at around US$68.54 is offering fair value or a potential mispricing opportunity? This article breaks down what the current share price might be telling you. The stock has recently moved, with returns of 7.4% over the last week, 6.8% over the last month, and 28.1% year to date. The return over the past year is down 2.6%, and up 56.6% over three years and 60.3% over five years. Recent coverage around Carrier Global has focused on its role in the building and HVAC...
NYSE:P
NYSE:PTech

Is It Too Late To Consider Everpure (P) After 4x Five Year Share Price Surge?

Wondering whether Everpure at US$78.51 is offering good value or asking too much of future expectations? This article walks through what the current price might be implying about the company. The stock has returned 7.5% over the past week, 5.2% over the last month, 13.8% year to date and 43.8% over the past year, with a very large gain over five years of about 4x. Recent coverage around Everpure has focused on its role in the broader tech sector and how investors are reassessing growth...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

A Look At Interparfums (IPAR) Valuation After Recent Share Price Weakness

Recent performance and context for Interparfums (IPAR) Interparfums (IPAR) has been on investors’ radar after a mixed period for the stock, with a modest gain in the past day contrasting with weaker moves over the past week and past 3 months. Over the past month the share price declined about 3%, and over the past 3 months it fell roughly 6%, while the stock is still up about 4% year to date. Over the past year, the total return declined about 33%, and over 3 years it declined about 29%,...
NYSE:GEO
NYSE:GEOCommercial Services

GEO Group (GEO) Is Up 8.8% After Newark, New Jersey Sue Over Detention Conditions

In early June 2026, New Jersey and the city of Newark filed lawsuits against GEO Group over alleged inhumane, unsanitary conditions at the Delaney Hall immigration detention facility and the company’s refusal to allow full state health inspections. The joint legal pressure from state and municipal authorities not only targets Delaney Hall’s operations but also elevates GEO Group’s regulatory and reputational exposure across its broader detention portfolio. We’ll examine how the legal push...
NYSE:IOT
NYSE:IOTSoftware

Why Samsara (IOT) Is Up 11.5% After Swinging To Q1 Profit And Raising 2027 Guidance – And What's Next

In early June 2026, Samsara Inc. reported first-quarter revenue of US$478.84 million, up from US$366.88 million a year earlier, and moved from a net loss of US$22.12 million to net income of US$44.51 million, with basic and diluted earnings per share both improving from a loss of US$0.04 to earnings of US$0.08. The company also issued guidance pointing to continued revenue growth and ongoing GAAP profitability for the second quarter and full fiscal 2027, highlighting momentum in annual...
NYSE:ONTO
NYSE:ONTOSemiconductor

Is It Too Late To Consider Onto Innovation (ONTO) After 191% One-Year Surge?

Wondering whether Onto Innovation at around US$274.76 is still reasonably priced after its strong run, or if you might be turning up late to the story. The stock has returned 6.2% over the past week, is down 9.9% over the past month, and sits on gains of 65.6% year to date and 191.3% over the past year, which can change how investors think about both upside and risk. Recent coverage around Onto Innovation has focused on its role within the semiconductor sector and how investors are reacting...
NasdaqCM:SWMR
NasdaqCM:SWMRAerospace & Defense

Swarmer Powerus Pact Extends Autonomy Software Reach As Valuation Stretches

Swarmer (NasdaqCM:SWMR) and Powerus have signed a Memorandum of Understanding to integrate Swarmer’s drone autonomy software into air and maritime autonomous systems. The collaboration targets defense, counter UAS, border security, and critical infrastructure protection use cases. The agreement extends Swarmer’s technology beyond its core drone market into broader multi domain autonomous platforms. Swarmer, trading at $72.81 under ticker NasdaqCM:SWMR, is coming off strong recent share...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley Tests AI Agents And IPO Roles For Future Fee Growth

Morgan Stanley (NYSE:MS) is opening its ShareWorks and Equity Edge stock administration platforms to autonomous AI agents, giving external tools direct access to key equity management workflows. The bank is also taking lead underwriting roles in planned AI and quantum technology IPOs, including Anthropic and Quantinuum. These moves put Morgan Stanley at the center of AI integration in equity administration and capital markets for next generation technology companies. Morgan Stanley enters...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

A Look At Principal Financial Group (PFG) Valuation As Fair Value Signals Clash With Recent Momentum

Recent performance snapshot Principal Financial Group (PFG) has drawn attention after recent share price moves, with the stock last closing at US$103.51. Investors are weighing this level against its recent returns, profitability profile, and current valuation signals. See our latest analysis for Principal Financial Group. The recent 2.3% 1 day share price return adds to a steady trend, with a 90 day share price return of 12.2% and a 5 year total shareholder return of 92.2%. This indicates...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

The Bull Case For Insmed (INSM) Could Change Following New Brinsupri Data And Hiring Push - Learn Why

At the 2026 American Thoracic Society conference held earlier this year, Insmed showcased encouraging post‑hoc Phase III data for Brinsupri, its first‑to‑market DPP‑1 inhibitor for non‑cystic fibrosis bronchiectasis, while also granting inducement stock awards to 103 new employees under its 2025 Inducement Plan. The combination of positive clinical signals for Brinsupri and expanded equity‑based hiring underscores Insmed’s effort to build both medical leadership and internal capabilities...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

Should Upcoming Canvuparatide Phase 2 Data Presentations Require Action From MBX Biosciences (MBX) Investors?

MBX Biosciences recently outlined its participation at the Jefferies Global Healthcare Conference in New York and scheduled a June 12, 2026 investor webcast and call to discuss new once-weekly canvuparatide data from ENDO 2026, including one-year open-label extension and full 12-week Phase 2 Avail trial results. These upcoming endocrinology-focused presentations highlight canvuparatide’s central role in MBX Biosciences’ pipeline and could refine how investors assess the company’s clinical...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

A Look At National Energy Services Reunited (NESR) Valuation After Its $729.6 Million Shelf Registration Filing

NESR shelf registration and what it could mean for investors National Energy Services Reunited (NESR) filed a shelf registration to potentially issue up to $729.6 million in ordinary shares, or 28,257,859 securities, giving the company added flexibility around future capital raising. See our latest analysis for National Energy Services Reunited. The shelf registration lands after a strong run in the stock, with a 90 day share price return of 21.43% and a year to date share price return of...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Assessing JD.com (NasdaqGS:JD) Valuation After 2026 618 Grand Promotion Reignites Investor Interest

JD.com (JD) has drawn fresh attention after its 2026 618 Grand Promotion logged record customer participation and broad online and offline growth, helping the stock rebound following recent pressure in key categories. See our latest analysis for JD.com. At a share price of $29.19, JD.com has recently swung between pressure from weaker electronics and home appliance sales and renewed interest tied to the 2026 618 Grand Promotion and margin gains in JD Retail, with short term share price...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark Holdings (CNK) Is Up 13.1% After Record May Box Office And Concession Spending Performance

Cinemark Holdings reported that May 2026 delivered its highest-ever domestic box office results, supported by a varied film slate and strong turnout, especially from younger audiences. The company also achieved record food and beverage spending per guest, underlining how concession monetization is becoming an increasingly powerful earnings driver alongside ticket sales. Next, we’ll examine how this record May performance, particularly the surge in concession spending, may influence...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Is Ulta Beauty (ULTA) Starting To Look Attractive After The Recent Share Price Slide?

Wondering if Ulta Beauty at US$462.52 is starting to look like value or if the stock still has more risk priced in? This article breaks down what the current share price might be implying. The stock has had a rough patch recently, with the share price falling 11.1% over the last week, 13.1% over the last month, and 25.4% year to date. The return over the last year is a smaller decline of 1.0%, and the 3 and 5 year returns are gains of 10.4% and 39.3% respectively. These moves sit against a...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Is Up 8.8% After ERAS-0015 Data And KRAS Patent Win Has The Bull Case Changed?

Erasca recently reported progress across its precision oncology pipeline, highlighting monotherapy efficacy and a favorable safety profile for lead candidate ERAS-0015 in KRAS G12X lung and pancreatic cancers, along with accelerated clinical development and new collaborations. The company also advanced its pan-KRAS inhibitor ERAS-4001, supported by a fresh US composition of matter patent that extends potential protection until 2043 and reinforces its position in targeted cancer...
NYSE:CNR
NYSE:CNROil and Gas

Why Core Natural Resources (CNR) Is Up 5.3% After Strong Q1 Free Cash Flow And Capital Returns

In early June 2026, Core Natural Resources released its latest investor presentation, reporting Q1 2026 revenue of US$1.10 billion, Adjusted EBITDA of US$179.9 million, net operating cash flow of US$119.4 million, free cash flow of US$55.5 million, and total liquidity of US$935.4 million. The company also returned US$47.0 million to shareholders in the quarter, underlining its focus on capital returns alongside maintaining substantial liquidity. We’ll now examine how this strong Q1 free cash...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Valuation In Focus As Short Interest Climbs And Insider Selling Meets Growth Story

Freshpet (FRPT) is back in focus after being flagged on June 3 as the consumer staples stock with the highest short interest, paired with recent insider share sales and, in contrast, constructive fundamental assessments. See our latest analysis for Freshpet. Despite the recent short interest spotlight and insider selling, Freshpet’s share price has fallen 18.2% over the past month and 40.4% over the past quarter, while the 1 year total shareholder return is down 39.2%. This suggests momentum...
NYSE:KNSL
NYSE:KNSLInsurance

Is Kinsale’s Q1 Revenue Miss Reframing the Investment Case For Kinsale Capital Group (KNSL)?

Kinsale Capital Group recently reported mixed first-quarter results, with revenue rising year over year but coming in below analyst expectations, highlighting the challenges of insuring hard-to-place and higher-risk clients. This earnings outcome has prompted investors to reassess how Kinsale’s niche focus and underwriting approach might influence its longer-term business prospects. We’ll now explore how Kinsale’s revenue shortfall against expectations may influence its investment narrative...
NYSE:AER
NYSE:AERTrade Distributors

Assessing AerCap Holdings (AER) Valuation After Recent Share Price Cooldown And Mixed Fair Value Signals

Recent performance snapshot AerCap Holdings (AER) has drawn fresh attention after recent trading left the stock down about 6% over the past month, even as its past 3 months return is roughly flat. For investors tracking the aircraft leasing sector, this short term pullback sits against a backdrop of a 19% total return over the past year and multi year gains that are several times higher than that. See our latest analysis for AerCap Holdings. Recent trading shows momentum cooling, with the...